1na2: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1na2]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1NA2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1NA2 FirstGlance]. <br> | <table><tr><td colspan='2'>[[1na2]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1NA2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1NA2 FirstGlance]. <br> | ||
</td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1na2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1na2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1na2 RCSB], [http://www.ebi.ac.uk/pdbsum/1na2 PDBsum]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1na2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1na2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1na2 RCSB], [http://www.ebi.ac.uk/pdbsum/1na2 PDBsum]</span></td></tr> | ||
<table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 15: | Line 15: | ||
==See Also== | ==See Also== | ||
*[[Telomerase|Telomerase]] | *[[Telomerase 3D structures|Telomerase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Feigon, J | [[Category: Feigon, J]] | ||
[[Category: Finger, L D | [[Category: Finger, L D]] | ||
[[Category: Theimer, C A | [[Category: Theimer, C A]] | ||
[[Category: Trantirek, L | [[Category: Trantirek, L]] | ||
[[Category: Hairpin]] | [[Category: Hairpin]] | ||
[[Category: Narrow minor groove]] | [[Category: Narrow minor groove]] | ||
Revision as of 14:01, 25 January 2015
Solution structure of the p2b hairpin from human telomerase RNASolution structure of the p2b hairpin from human telomerase RNA
Structural highlights
Publication Abstract from PubMedAutosomal dominant dyskeratosis congenita (DKC), as well as aplastic anemia, has been linked to mutations in the RNA component of telomerase, the ribonucleoprotein responsible for telomere maintenance. Here we examine the effect of the DKC mutations on the structure and stability of human telomerase RNA pseudoknot and CR7 domains by using NMR and thermal melting. The CR7 domain point mutation decreases stability and alters a conserved secondary structure thought to be involved in human telomerase RNA accumulation in vivo. We find that pseudoknot constructs containing the conserved elements of the pseudoknot domain are in equilibrium with a hairpin conformation. The solution structure of the wild-type hairpin reveals that it forms a continuous helix containing a novel run of three consecutive U.U and a U.C base pairs closed by a pentaloop. The six base pairs unique to the hairpin conformation are phylogenetically conserved in mammals, suggesting that this conformation is also functionally important. The DKC mutation in the pseudoknot domain results in a shift in the equilibrium toward the hairpin form, primarily due to destabilization of the pseudoknot. Our results provide insight into the effect of these mutations on telomerase structure and suggest that the catalytic cycle of telomerase involves a delicate interplay between RNA conformational states, alteration of which leads to the disease state. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA.,Theimer CA, Finger LD, Trantirek L, Feigon J Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):449-54. Epub 2003 Jan 13. PMID:12525685[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||